TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T09909	Angiotensin II receptor type-2	B5IA3F	Tert-butyl N-[[(2S,3S)-2-[[3-(imidazol-1-ylmethyl)benzoyl]amino]-3-methylpentanoyl]amino]carbamate	Investigative	73213253	C22H31N5O4	429.5	CC[C@H](C)[C@@H](C(=O)NNC(=O)OC(C)(C)C)NC(=O)C1=CC=CC(=C1)CN2C=CN=C2	Ki ~ 100000 nM	Poor binder
T09909	Angiotensin II receptor type-2	BMQ5B6	N-[(2S,3S)-1-[2-(Benzenesulfonyl)hydrazinyl]-3-methyl-1-oxopentan-2-yl]-3-(imidazol-1-ylmethyl)benzamide	Investigative	73213177	C23H27N5O4S	469.6	CC[C@H](C)[C@@H](C(=O)NNS(=O)(=O)C1=CC=CC=C1)NC(=O)C2=CC=CC(=C2)CN3C=CN=C3	Ki ~ 100000 nM	Poor binder
T09909	Angiotensin II receptor type-2	BQ6ZX0	N-[(2S,3S)-1-(2-Butylsulfonylhydrazinyl)-3-methyl-1-oxopentan-2-yl]-3-(imidazol-1-ylmethyl)benzamide	Investigative	73213255	C21H31N5O4S	449.6	CCCCS(=O)(=O)NNC(=O)[C@H]([C@@H](C)CC)NC(=O)C1=CC=CC(=C1)CN2C=CN=C2	Ki ~ 100000 nM	Poor binder
T09909	Angiotensin II receptor type-2	BSZY23	(2S,3S)-2-[[3-(Imidazol-1-ylmethyl)benzoyl]amino]-3-methylpentanoic acid;2,2,2-trifluoroacetic acid	Investigative	76313892	C19H22F3N3O5	429.4	CC[C@H](C)[C@@H](C(=O)O)NC(=O)C1=CC=CC(=C1)CN2C=CN=C2.C(=O)(C(F)(F)F)O	Ki = 110000 nM	Poor binder
T09909	Angiotensin II receptor type-2	BXOE19	3-(Imidazol-1-ylmethyl)-N-[(2S,3S)-3-methyl-1-oxo-1-(2-pentylsulfonylhydrazinyl)pentan-2-yl]benzamide	Investigative	73213256	C22H33N5O4S	463.6	CCCCCS(=O)(=O)NNC(=O)[C@H]([C@@H](C)CC)NC(=O)C1=CC=CC(=C1)CN2C=CN=C2	Ki ~ 100000 nM	Poor binder